Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Tharimmune, Inc.

Equities

THAR

US4327053090

Real-time Estimate Cboe BZX
Other stock markets
 03:53:02 2024-06-20 pm EDT 		5-day change 1st Jan Change
3.07 USD +3.54% Intraday chart for Tharimmune, Inc. -7.49% -59.53%
07:19pm Tharimmune Prices $2.1 Million Private Placement of Common Shares, Warrants MT
Jun. 17 Tharimmune, Inc. Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, Its Lead Candidate for Moderate-To-Severe Pruritus in Primary Biliary Cholangitis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
THARIMMUNE, INC. Stock Tharimmune, Inc.
 2.33M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.57B -
BIONTECH SE Stock BioNTech SE
 20.82B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 16.3B -
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Charts Tharimmune, Inc.
  5. Sector Chart